Brought to you by 
Portola raises $21mm in Series A financing
06 Apr 2021
Executive Summary
Newly established Portola Pharmaceuticals Inc. (developing treatments for cardiovascular diseases) brought in $21mm through a Series A placement led by Sutter Hill Ventures, Prospect Ventures, and MPM Capital. Abingworth Management and Frazier Healthcare Ventures also participated.
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Portola raises $21mm in Series A financing
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice